Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find attached the Scrutinizer''s Report on the business transacted at the 17th ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Limited held its 17th AGM on Friday, 25th July 2025 at 3:00 PM via video conferencing. The company filed the Scrutinizer's Report (by Vishal N. Manseta, Practicing Company Secretary) detailing the e-voting results on 5 resolutions. The cut-off date for voting was 18th July 2025, with 1,395 shareholders on record; 17 shareholders attended via video conferencing and 26 cast votes through remote e-voting, while none voted during the AGM itself. Resolutions included adoption of audited financial statements for FY ended 31st March 2025, reappointment of Dr. Anil Ghogare (DIN: 00432559) as director retiring by rotation, revision of remuneration for Chairman & MD Hemal Mehta and Joint MD Sachin Mehta (both special resolutions), and appointment of Vishal Manseta as Secretarial Auditor for FY 2025-26 to FY 2029-30.
Shareholders have formally approved the FY25 financial statements and management remuneration revisions. The reappointment of the existing director and the 5-year appointment of the secretarial auditor are now confirmed. The high remote e-voting participation versus in-meeting attendance is consistent with the post-pandemic AGM format and has no negative implication for the stock.